Artículo
Economic Impact of PromarkerD In Vitro Diagnostic Testing on the Management of Chronic Kidney Disease in Type 2 Diabetes: A Budget Impact Analysis.
Research record from Pharmacoecon Open, 2026-07-10. PMID 42432212.
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Artículo
Research record from Pharmacoecon Open, 2026-07-10. PMID 42432212.
Pruebas
The determination of the number of a sub-population of effector 2 B-lymphocytes in a sample.
Indicadores
This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.
Indicadores
This gene is involved in nucleotide excision repair and corrects sensitivity to UV radiation and defective nucleotide excision repair in xeroderma pigmentosum cells of complementation group D.
Pruebas
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgA antibodies against SARS-CoV-2 using the S1 domain of the spike protein.
Pruebas
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
Pruebas
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using a modified nucleocapsid protein (NCP) containing only diagnostically relevant epitopes.
Pruebas
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgM antibodies against SARS-CoV-2 using a modified nucleocapsid protein (NCP) containing only diagnostically relevant epitopes.
Pruebas
A proprietary enzyme-linked immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
Artículo
Research record from J Clin Virol, 2026-04-27. PMID 42054824.
Indicadores
A derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production. (NCI05)
Artículo
Research record from Cancer Cytopathol, 2026-05-01. PMID 42046206.